Clinical Trials Directory

Trials / Completed

CompletedNCT03463824

The VIGOR Study - Virtual Immersive Gaming to Optimize Recovery in Low Back Pain

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
154 (actual)
Sponsor
Virginia Commonwealth University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study will measure the effects of interactive, whole-body video games on movement behavior in people with chronic low back pain.

Detailed description

A fundamental clinical problem in individuals with chronic low back pain is the significant alteration in movement patterns that restrict lumbar spine motion. This restriction of lumbar motion is particularly evident in patients with kinesiophobia; that is, a fear of movement due to possible injury or reinjury. For chronic back pain patients with kinesiophobia it is critical to develop an effective intervention to increase spine motion while minimizing concerns of pain and harm. Accordingly, we have developed a innovative video games that track whole-body motion and are designed to encourage spinal flexion while reducing concerns of pain and harm among individuals with low back pain. Our games have two distinct advantages. First, within this video game environment, visual feedback can be altered by changing the feedback gain of a given movement (e.g., the magnitude of a given joint movement could appear on screen as either larger or smaller than the actual movement). Thus, gain manipulation will result in progressively larger amounts of lumbar spine flexion during game play. Second, video games are potent distractors that can reduce attention to pain.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExperimental Group 1Participants will complete 18 intervention visits over 9 weeks with the number of sessions tapered across weeks (i.e., 3 sessions/week in weeks 1-3, 2 sessions/week in weeks 4-6, and 1 session/week in weeks 7-9).
BEHAVIORALExperimental Group 2Participants will complete 18 intervention visits over 9 weeks with the number of sessions tapered across weeks (i.e., 3 sessions/week in weeks 1-3, 2 sessions/week in weeks 4-6, and 1 session/week in weeks 7-9).

Timeline

Start date
2019-01-10
Primary completion
2023-10-14
Completion
2023-10-14
First posted
2018-03-13
Last updated
2025-02-05
Results posted
2025-02-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03463824. Inclusion in this directory is not an endorsement.